Product & Industry News
Page 1 to 16 of 120 |     NEXT PAGE >
Endomag’s Magseed marker receives FDA clearance for long-term and soft tissue implantation
Endomag, has announced that it has received 510(k) clearance from the U.S. FDA to extend the indication of its Magseed magnetic marker to include both the marking of soft tissue and long-term implantation.

Read More

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales
Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales.

Read More

Fraunhofer and Mologic partner on point-of-care diagnosis and antibiotic susceptibility test for UTIs
Mologic Ltd, and Fraunhofer Centre for Applied Photonics, have announced they are working together to develop a rapid, point-of-care test to immediately diagnose bacterial urinary tract infections (UTIs) and any associated antibiotic susceptibility, in a primary care setting.

Read More

Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology
The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

Read More

Horizon Discovery enters into license agreement with US immuno-oncology company
Horizon Discovery Group plc, today announces that it has entered into a non-exclusive out-licensing agreement with a US-based immuno-oncology therapeutics developer for Horizon’s proprietary technologies.

Read More

Lonza Expands Cell-Culture Portfolio with Quasi Vivo System
Today Lonza announced the latest addition to its cell-culture product portfolio – the Quasi Vivo System.

Read More

ADC Bio developing downstream bioconjugation process
ADC Biotechnology (ADC Bio) announces that it is developing a revolutionary, ‘downstream bioconjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing.

Read More

SBRI Healthcare backs high potential cancer screening technologies
£1 million awarded to develop innovations for earlier and faster diagnosis

Read More

Enamine and BioSolveIT Launch the World's Largest Searchable Chemical Space for Novel Compound Sourcing
Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks and screening compound libraries, and BioSolveIT GmbH, announced the launch of the ‘REAL Space Navigator’.

Read More

Symcel expands staff for clinical market growth and Horizon 2020 funded validation of antimicrobial susceptibility testing
Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener – is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets.

Read More

Lonza Present Latest Research into More Physiologically Relevant ADME-Tox Models
During the Society of Toxicology Meeting from 11-15 March 2018, Lonza will present two posters highlighting its latest research into developing more physiologically relevant in vitro cell-culture models for ADME-Tox testing.

Read More

TTP Labtech’s global launch of dragonfly discovery at SLAS 2018
New liquid handling platform reduces assay development time and improves assay robustness in high throughput screening. Global commercial launch at SLAS 2018 from 3rd to 7th February 2018, in San Diego, CA, Booth #1219.

Read More

Concept Life Sciences Group acquired by Spectris plc
Acquisition increases Concept’s global reach and supports growth strategy. Synergies with Spectris’ molecular testing and analysis expertise will provide customers with access to a broader range of services.

Read More

Avacta and Oncosec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers
Avacta Group plc and OncoSec Medical Incorporated, are pleased to announce they have entered into a research collaboration to combine Avacta’s Affimer protein platform with OncoSec’s gene delivery technology ImmunoPulse.

Read More

LifeArc and Milner Therapeutics Institute announce a new partnership in artificial intelligence and machine learning for target discovery
LifeArc, the UK-based medical research charity, and the Milner Therapeutics Institute at the University of Cambridge, have announced a new partnership to identify and validate new drug targets in immuno-oncology and respiratory diseases.

Read More

IONTAS to Generate Antibodies using Mammalian Display Technology for a Global Biopharma
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, announced today that it has signed an agreement with Sanofi to discover antibodies using IONTAS’ proprietary Mammalian Display Technology.

Read More

Product & Industry News
Page 1 to 16 of 120 |     NEXT PAGE >